$Agenus (AGEN.US)$Benzinga· 3 mins ago Agenus Announced Five Presentations Featuring Botensilimab (Bot, An Fc-enhanced Anti-CTLA-4 Antibody) Plus Balstilimab (Bal, An Anti-PD-1 Antibody) At The Upcoming American Society Of Clinical Oncology Gastrointestinal Cancers Symposium
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more